Tuğçe İnce
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tuğçe İnce has a total of 142 co-authors. Here are the top co-authors by number of shared publications:
- Dilara Ece Toprak
Division of Pediatric Neurology, Department of Pediatrics, Faculty of Medicine, Ege University, İzmir, Turkey
5 shared publications - Hasan Tekgül
Division of Pediatric Neurology, Department of Pediatrics, Ege University Faculty of Medicine, Izmir, Turkiye
4 shared publications - Sanem Yilmaz
Department of Pediatrics, Division of Child Neurology, Ege University Medical Faculty, Turkey
4 shared publications - Seda Kanmaz
Department of Pediatric Neurology, Faculty of Medicine, Ege University, Izmir, Turkey
4 shared publications - Cemile Busra Olculu
Division of Pediatric Neurology, Department of Pediatrics, Faculty of Medicine, Ege University, İzmir, Turkey
3 shared publications - Sarenur Gökben
Department of Pediatrics, Division of Child Neurology Ege University Medical Faculty İzmir Turkey
3 shared publications
Latest Publications
- 7 January 2025
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 54, 89-95
Etiology-specific subgroup analysis of initial pharmacotherapy in infantile epileptic spasm syndrome: A single-center cohort study
- 7 January 2025
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 54, 89-95
Etiology-specific subgroup analysis of initial pharmacotherapy in infantile epileptic spasm syndrome: A single-center cohort study
- 21 September 2024
- Published by Academician Publishing
- p. 151-166
Yenidoğan Dönemi Konvülziyonları ve Epilepsileri
Yenidoğan (YD) nöbetlerinin tanımlanmasında altın standart sürekli elektroensefalografi (EEG) monitorizasyonudur. Güncel (2021) YD nöbet sınıflamasında klinik nöbet tanısı için EEG eşleniği şarttır. YD nöbetlerinin %80’lik kısmını akut semptomatik nöbetler oluşturur. Hipoglisemi, elektrolit bozuklukları ve altta yatan olası enfeksiyöz nedenler gibi acil tedavi edilebilir sebeplerin belirlenmesi ile akut semptomatik nöbetlerin birçoğu anti-nöbet ilaca ihtiyaç duyulmaksızın önlenebilir. Hipoksik iskemik ensefalopatinin erken tanınması ve erken terapötik hipotermi uygulaması nöbet kontrolünün sağlanması ve uzun dönem prognoz açısından önemlidir. Anti nöbet ilaca dirençli YD konvülziyonlarında tedavi edilebilir nedenler açısından B6 vitamini, folinik asit ve biyotin tedavileri akılda bulundurulmalı ve genetik sonuçları gelene dek tedaviler sürdürülmelidir. Continuous electroencephalography (cEEG) is the gold standard for identifying neonatal seizures. A linical seizure diagnosis in the 2021 NNS classification requires an EEG correlate. Acute symptomatic seizures account for 80% of neonatal seizures and many can be prevented by recognizing treatable causes such as hypoglycemia, electrolyte imbalances, and infectious causes, without the need for anti-seizure medication (ASM). Early recognition of hypoxic-ischemic encephalopathy and the early application of therapeutic hypothermia are important for seizure control and long-term prognosis. Vitamin B6, folinic acid, and biotin supplements should be considered for treatable causes of ASM-resistant neonatal seizures and continued until genetic results are obtained.
- 21 September 2024
- Published by Academician Publishing
- p. 151-166
Yenidoğan Dönemi Konvülziyonları ve Epilepsileri
Yenidoğan (YD) nöbetlerinin tanımlanmasında altın standart sürekli elektroensefalografi (EEG) monitorizasyonudur. Güncel (2021) YD nöbet sınıflamasında klinik nöbet tanısı için EEG eşleniği şarttır. YD nöbetlerinin %80’lik kısmını akut semptomatik nöbetler oluşturur. Hipoglisemi, elektrolit bozuklukları ve altta yatan olası enfeksiyöz nedenler gibi acil tedavi edilebilir sebeplerin belirlenmesi ile akut semptomatik nöbetlerin birçoğu anti-nöbet ilaca ihtiyaç duyulmaksızın önlenebilir. Hipoksik iskemik ensefalopatinin erken tanınması ve erken terapötik hipotermi uygulaması nöbet kontrolünün sağlanması ve uzun dönem prognoz açısından önemlidir. Anti nöbet ilaca dirençli YD konvülziyonlarında tedavi edilebilir nedenler açısından B6 vitamini, folinik asit ve biyotin tedavileri akılda bulundurulmalı ve genetik sonuçları gelene dek tedaviler sürdürülmelidir. Continuous electroencephalography (cEEG) is the gold standard for identifying neonatal seizures. A linical seizure diagnosis in the 2021 NNS classification requires an EEG correlate. Acute symptomatic seizures account for 80% of neonatal seizures and many can be prevented by recognizing treatable causes such as hypoglycemia, electrolyte imbalances, and infectious causes, without the need for anti-seizure medication (ASM). Early recognition of hypoxic-ischemic encephalopathy and the early application of therapeutic hypothermia are important for seizure control and long-term prognosis. Vitamin B6, folinic acid, and biotin supplements should be considered for treatable causes of ASM-resistant neonatal seizures and continued until genetic results are obtained.
- 31 May 2024
- Published by Elsevier in Pediatric Neurology
- Vol. 157, 100-107
The Utility of Genetic Testing in Infantile Epileptic Spasms Syndrome: A Step-Based Approach in the Next-Generation Sequencing Era
- 31 May 2024
- Published by Elsevier in Pediatric Neurology
- Vol. 157, 100-107
The Utility of Genetic Testing in Infantile Epileptic Spasms Syndrome: A Step-Based Approach in the Next-Generation Sequencing Era
- 1 March 2023
- Published by Galenos Yayinevi in The Journal of Pediatric Research
- Vol. 10 (1) , 19-25
The Prophylaxis of Febrile Convulsions in Childhood: Secular Trends in the Last Decade (2007-2008 versus 2017-2018)
- 1 March 2023
- Published by Galenos Yayinevi in The Journal of Pediatric Research
- Vol. 10 (1) , 19-25
The Prophylaxis of Febrile Convulsions in Childhood: Secular Trends in the Last Decade (2007-2008 versus 2017-2018)
- Open Access
- 1 March 2023
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 58 (2) , 142-153
Assessment of Prognostic Factors and Validity of Scoring Models in Childhood Autoimmune Encephalitis
Objective: The aim of this study is to evaluate the prognostic factors in a single-center pediatric cohort with autoimmune encephalitis. Materials and Methods: The study group consisted of 23 pediatric autoimmune encephalitis patients (seropositive autoimmune encephalitis: 15, seronegative autoimmune encephalitis: 8). Five group prognostic parameters were evaluated: clinical manifestations, elect roenc ephal ograp hy features, magnetic resonance imaging characteristics, biomarkers, and treatment modalities. Three scoring models were applied: the Antibody Prevalence in Epilepsy and Response to Immunotherapy in Epilepsy for predicting autoimmune-related epilepsy in the whole cohort and the anti-N-methyl-d-aspartate receptor Encephalitis 1-Year Functional Status score for overall outcome in patients with anti-N-methyl-d-aspartate receptor encephalitis. Results: The initial clinical spectrum of the disease was similar in the seronegative and seropositive groups. Almost half of the patients (48%) recovered without any complications with first-line immunotherapy. The patients with movement disorders in the acute phase of the disease needed more likely second-line immunotherapy (P = .039). The presence of status epilepticus at admission was significantly associated with adverse outcomes and the development of autoimmune-related epilepsy (P = .019). Autoimmune-related epilepsy was defined in an equal proportion of patients (91.5%) with 2 immune epilepsy scores (Antibody Prevalence in Epilepsy and Response to Immunotherapy in Epilepsy). The N-methyl-d-aspartate receptor Encephalitis 1-Year Functional Status score and the modified Rankin score assessed for the first-year prognosis were strongly correlated among the patients with anti-N-methyl-d-aspartate receptor encephalitis (P = .03, Spearmen’s rho = 0.751). Conclusions: The presence of status epilepticus was the most important prognostic factor in the patients with the adverse outcome. The studied scoring models (Anti-N-methyl-d-aspartate receptor Encephalitis 1-Year Functional Status, Antibody Prevalence in Epilepsy, and Response to Immunotherapy in Epilepsy) have also been proven to be applicable to the pediatric age group for predicting overall outcome and autoimmune-related epilepsy. Cite this article as: Kanmaz S, Yılmaz S, Toprak DE, et al. Assessment of prognostic factors and validity of scoring models in childhood autoimmune encephalitis. Turk Arch Pediatr. 2023;58(2):142-153.
- 1 March 2023
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 58 (2) , 142-153
Open AccessAssessment of Prognostic Factors and Validity of Scoring Models in Childhood Autoimmune Encephalitis
Objective: The aim of this study is to evaluate the prognostic factors in a single-center pediatric cohort with autoimmune encephalitis. Materials and Methods: The study group consisted of 23 pediatric autoimmune encephalitis patients (seropositive autoimmune encephalitis: 15, seronegative autoimmune encephalitis: 8). Five group prognostic parameters were evaluated: clinical manifestations, elect roenc ephal ograp hy features, magnetic resonance imaging characteristics, biomarkers, and treatment modalities. Three scoring models were applied: the Antibody Prevalence in Epilepsy and Response to Immunotherapy in Epilepsy for predicting autoimmune-related epilepsy in the whole cohort and the anti-N-methyl-d-aspartate receptor Encephalitis 1-Year Functional Status score for overall outcome in patients with anti-N-methyl-d-aspartate receptor encephalitis. Results: The initial clinical spectrum of the disease was similar in the seronegative and seropositive groups. Almost half of the patients (48%) recovered without any complications with first-line immunotherapy. The patients with movement disorders in the acute phase of the disease needed more likely second-line immunotherapy (P = .039). The presence of status epilepticus at admission was significantly associated with adverse outcomes and the development of autoimmune-related epilepsy (P = .019). Autoimmune-related epilepsy was defined in an equal proportion of patients (91.5%) with 2 immune epilepsy scores (Antibody Prevalence in Epilepsy and Response to Immunotherapy in Epilepsy). The N-methyl-d-aspartate receptor Encephalitis 1-Year Functional Status score and the modified Rankin score assessed for the first-year prognosis were strongly correlated among the patients with anti-N-methyl-d-aspartate receptor encephalitis (P = .03, Spearmen’s rho = 0.751). Conclusions: The presence of status epilepticus was the most important prognostic factor in the patients with the adverse outcome. The studied scoring models (Anti-N-methyl-d-aspartate receptor Encephalitis 1-Year Functional Status, Antibody Prevalence in Epilepsy, and Response to Immunotherapy in Epilepsy) have also been proven to be applicable to the pediatric age group for predicting overall outcome and autoimmune-related epilepsy. Cite this article as: Kanmaz S, Yılmaz S, Toprak DE, et al. Assessment of prognostic factors and validity of scoring models in childhood autoimmune encephalitis. Turk Arch Pediatr. 2023;58(2):142-153.